Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation.

McQuaid F, Jones C, Stevens Z, Meddaugh G, O'Sullivan C, Donaldson B, Hughes R, Ford C, Finn A, Faust SN, Gbesemete D, Bedford H, Hughes S, Varghese AS, Heath PT, Snape MD.

Acta Obstet Gynecol Scand. 2018 Mar;97(3):330-340. doi: 10.1111/aogs.13288. Epub 2018 Jan 19.

PMID:
29292509
2.

Non-specific immunological effects of selected routine childhood immunisations: systematic review.

Kandasamy R, Voysey M, McQuaid F, de Nie K, Ryan R, Orr O, Uhlig U, Sande C, O'Connor D, Pollard AJ.

BMJ. 2016 Oct 13;355:i5225. doi: 10.1136/bmj.i5225. Review.

3.

Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionals.

McQuaid F, Pask S, Locock L, Davis E, Stevens Z, Plumb J, Snape MD.

Vaccine. 2016 Jul 25;34(34):4056-61. doi: 10.1016/j.vaccine.2016.06.024. Epub 2016 Jun 16.

PMID:
27318418
4.

Factors influencing women's attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: an online survey.

McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, Voysey M, Heath PT, Snape MD.

BMJ Open. 2016 Apr 20;6(4):e010790. doi: 10.1136/bmjopen-2015-010790.

5.

Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months.

McQuaid F, Snape MD, John TM, Kelly S, Robinson H, Yu LM, Toneatto D, D'Agostino D, Dull PM, Pollard AJ.

CMAJ. 2015 Apr 21;187(7):E215-E223. doi: 10.1503/cmaj.141200. Epub 2015 Mar 23.

6.

A vomiting baby.

McQuaid F, Long AM, Warne SA.

BMJ. 2015 Jan 6;350:h14. doi: 10.1136/bmj.h14. No abstract available.

PMID:
25568960
7.

Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age.

McQuaid F, Snape MD, John TM, Kelly S, Robinson H, Houlden J, Voysey M, Toneatto D, Kitte C, Dull PM, Pollard AJ.

Pediatr Infect Dis J. 2014 Jul;33(7):760-6. doi: 10.1097/INF.0000000000000327.

PMID:
24722351
8.

Will booster doses be required for serogroup B meningococcal vaccine?

McQuaid F, Snape MD.

Expert Rev Vaccines. 2014 Mar;13(3):313-5. doi: 10.1586/14760584.2014.878654. Epub 2014 Jan 23.

PMID:
24451002
9.

Attitudes towards vaccination against group B streptococcus in pregnancy.

McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, Heath PT, Matthew D Snape.

Arch Dis Child. 2014 Jul;99(7):700-1. Epub 2013 Dec 19. No abstract available.

PMID:
24356806
10.

Contingency management for substance misuse.

McQuaid F, Bowden-Jones O, Weaver T.

Br J Psychiatry. 2007 Mar;190:272; author reply 272. No abstract available.

PMID:
17329758

Supplemental Content

Loading ...
Support Center